GE HealthCare Launches Invenia ABUS Prime and ABUS StreamVue for Dense Breast Screening

Following the introduction of Invenia™ ABUS Prime at the Society of Breast Imaging Annual Symposium, the installation at BeSound in Los Angeles...

August 05, 2026 | Wednesday | News
Pathos AI and AstraZeneca Partner to Advance AZD4241 for ER+/HER2- Breast Cancer

Pathos assumes responsibility for early clinical development of AZD4241, utilizing its AI-driven Foundry platform to drive patient stratification and t...

August 05, 2026 | Wednesday | News
Medicus Pharma Receives UAE IND Clearance for Phase 2a Endometriosis Study of Teverelix

Medicus Pharma Ltd. (NASDAQ: MDCX) (“Medicus” or the “Company”), a biotech/life sciences company focused on advancing the clinica...

August 04, 2026 | Tuesday | News
Huonslab Secured Patent for HyDIFFUZE™-Based Subcutaneous ADC Formulation Technology

Demonstrates competitiveness of hyaluronidase-based ADC SC conversion platform Confirms stability of high-concentration ADC SC formulations and improv...

July 29, 2026 | Wednesday | News
BioTalent Canada and BAM Partner to Expand AI Training for Manitoba’s Bio-Economy

  BioTalent Canada and Bioscience Association Manitoba (BAM) today announced a collaboration to expand access to “AI Fundamentals for the Bio-e...

July 24, 2026 | Friday | News
Senhwa Biosciences Secured NT$500 Million Equity Commitment from GEM

GEM Global Yield LLC SCS ("GEM") has executed a Share Purchase Agreement (the "SPA") with the existing shareholders of Taiwan-listed Senhwa Biosciences Inc...

July 17, 2026 | Friday | News
Primrose Bio Secured $2 Million NIH Grant to Advance DNA- and RNA-Based Medicine Research

$2 million grant builds on research to develop sequence elements that improve DNA- and RNA-based medicine efficacy Primrose Bio, Inc., a company with pr...

July 17, 2026 | Friday | News
Anixa Biosciences Secures Australian Patent Acceptance for Breast Cancer Vaccine Technology

Notice of Acceptance marks first Australian patent covering Anixa's breast cancer vaccine platform Continues expansion of global intellectual property c...

July 16, 2026 | Thursday | News
Biocytogen Partners with Whitehawk Therapeutics to Develop Bispecific ADCs

Biocytogen  and Whitehawk Therapeutics, Inc.  announced a global collaboration to develop bispecific antibody-drug conjugates (BsADC). Biocytog...

July 09, 2026 | Thursday | News
Brii Bio Phase 2b ENRICH Data Strengthens BRII-179 Immune Priming Strategy for Functional Hepatitis B Cure

End-of-treatment data from ENRICH demonstrated higher HBsAg loss rates, consistent with ENSURE Cohort 4, confirming the role of BRII-179 in priming imm...

July 06, 2026 | Monday | News
Liminatus Pharma Revises Merger Agreement with InnocsAI to Accelerate Strategic Combination

Liminatus Pharma, Inc. (Nasdaq: LIMN) ("Liminatus" or the "Company"), a biotechnology company developing innovative cancer therapies, announced that it h...

July 02, 2026 | Thursday | News
Roche Launches AXELIOS 1 Sequencing Platform to Accelerate Same-Day Whole-Genome Research

AXELIOS 1 delivers a unique combination of accuracy, speed, scalability and cost efficiency, giving laboratories of all sizes the freedom to customise ...

June 30, 2026 | Tuesday | News
China Approves First-in-Class Bispecific ADC Iza-bren for Advanced Nasopharyngeal Carcinoma

First regulatory approval for iza-bren (BL-B01D1), a first-in-class EGFR×HER3 bispecific antibody-drug conjugate (ADC) Represents an important n...

June 24, 2026 | Wednesday | News
Indiana Unveils ‘BioHeartland Indiana’ to Showcase Its $125 Billion Bioscience Economy

New regional identity unites a more than $100 billion bioscience ecosystem and positions Indiana among the world's leading innovation hubs. BIO Internat...

June 24, 2026 | Wednesday | News

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

× Please select an option to participate in the poll.
Processing...
× You have successfully cast your vote.
 {{ optionDetail.option }}  {{ optionDetail.percentage }}%
 {{ optionDetail.percentage }}% Complete
More polls
Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

© 2026 Biopharma Boardroom. All Rights Reserved.

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close